1. Home
  2. ALOT vs LUNG Comparison

ALOT vs LUNG Comparison

Compare ALOT & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AstroNova Inc.

ALOT

AstroNova Inc.

HOLD

Current Price

$9.53

Market Cap

56.7M

Sector

Technology

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.95

Market Cap

63.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALOT
LUNG
Founded
1969
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.7M
63.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ALOT
LUNG
Price
$9.53
$1.95
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$6.81
AVG Volume (30 Days)
22.4K
636.2K
Earning Date
12-10-2025
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$150,340,000.00
$91,664,000.00
Revenue This Year
N/A
$9.21
Revenue Next Year
N/A
$5.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.59
52 Week Low
$6.96
$1.31
52 Week High
$13.38
$9.37

Technical Indicators

Market Signals
Indicator
ALOT
LUNG
Relative Strength Index (RSI) 69.28 40.77
Support Level $8.95 $2.18
Resistance Level $9.59 $2.39
Average True Range (ATR) 0.32 0.15
MACD 0.13 -0.06
Stochastic Oscillator 96.17 5.43

Price Performance

Historical Comparison
ALOT
LUNG

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: